Global nanomed market, driven by brain delivery, is expected to reach $177B by 2019

Analysts predict the global market for nanotechnology in medicine, which amounted to almost $79 billion in 2012, will surpass $177 billion by 2019. According to Transparency Market Research, the industry is expected to grow at a rate of about 12.3% a year for the next 6 years. Dominating the market is the oncology sector, its most significant area of growth driven by nanomedicines delivering drugs to tumors in the brain. But the cardiovascular market could also play a key role. And the analysts note that, although North America led the market in 2012 and is expected to hold that position, Asia and Europe could grow at a faster rate. More

Suggested Articles

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.

Researchers at Johns Hopkins have changed the structure of a new cancer drug to allow it to more easily pass the blood-brain barrier, giving it access to…

Medtronic’s world-first FDA-approved hybrid closed-loop insulin delivery system might soon face competition, as T1D Exchange has pledged to invest in the…